Wei H, Zhou C, Lin D, Liu B, Li Y, Zhao X, Wei S, Gong B, Liu K, Gong X, Liu Y, Zhang G, Chen J, Zhang J, Jin J, Qiu S, Gu R, Wang Y, Mi Y, Wang J. Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia. haematol [Internet]. 2021Apr.30 [cited 2026Feb.8];106(5):1491-5. Available from: https://haematologica.org/article/view/haematol.2020.267526